GILEAD SCIENCES, INC. for GILEAD SCIENCES INC

Veterans VET

Education related to antivirals and oncology products.

Contacted: Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE; Commerce, Dept of (DOC); White House Office; Office of the Vice President of the United States; U.S. Trade Representative (USTR)

Trade (domestic/foreign) TRD

International trade and protection of intellectual property; compulsory licensing and other IP issues in multiple countries.

Contacted: Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); U.S. Trade Representative (USTR); SENATE; Food & Drug Administration (FDA); White House Office; Office of the Vice President of the United States

Medicare/Medicaid MMM

Administration drug pricing proposals. HCV testing, screening and linkage to care programs. Medicaid and Medicare coverage, access and reimbursement issues for Hepatitis C, HIV, and oncology products. Medicare Part D reform and benefit redesign. 2021 Notice of Benefit and Payment Parameters (NBPP) proposed rule and CMS rules related to hospital inpatient payments and value-based purchasing arrangements. S.2543 - The Prescription Drug Pricing Reduction Act of 2019 S.3129 - Lower Costs, More Cures Act of 2019 H.R.3 - Lower Drug Costs Now Act of 2019 H.R.19 - Lower Costs, More Cures Act of 2019 H.R.259 - Medicaid Extenders Act of 2019

Contacted: Food & Drug Administration (FDA); State, Dept of (DOS); White House Office; HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Office of the Vice President of the United States; Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); SENATE; Office of Management & Budget (OMB); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 3129 (116th), H.R. 19 (116th), H.R. 3 (116th), S. 2543 (116th), H.R. 259 (116th)

Copyright/Patent/Trademark CPT

Issues related to pharmaceuticals and intellectual property protection including technology transfer, patent rights and funding.

Contacted: Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); SENATE; Centers For Medicare and Medicaid Services (CMS); Office of the Vice President of the United States; Food & Drug Administration (FDA); White House Office; U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); State, Dept of (DOS); Office of Management & Budget (OMB)

Health Issues HCR

Expanding access to HIV treatment and prevention therapies including, Administration proposals; Ryan White Care Act reauthorization; PEPFAR reauthorization; HIV/AIDS access to care, research, testing and treatment. HCV screening and linkage to care programs; coverage and reimbursement policy for HCV, HIV and oncology portfolio. Pharmaceutical policy as it relates to payments under the 340B program. Highlighting Gilead's efforts to ensure diversity in clinical trials. Issues related to developing treatment for COVID-19 (2019 Novel Coronavirus), including: clinical trials, expanded access, compassionate use program, emergency use authorization, donation, distribution and allocation of remdesivir. H.R.6201 - Families First Coronavirus Response Act H.R.748 / S.3548 - CARES Act H.R.3 - Lower Drug Costs Now Act of 2019 S.2543 - Prescription Drug Pricing Reduction Act of 2019 S.3013 - Encouraging Innovate Benefit Design to Lower Costs for Seniors Act H.R.6800 - The Heroes Act

Contacted: Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Office of the Vice President of the United States; Office of Management & Budget (OMB); SENATE; State, Dept of (DOS); White House Office; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES

Bills named: S. 2543 (116th), H.R. 6201 (116th), S. 3013 (116th), H.R. 3 (116th), S. 3548 (116th), H.R. 748 (116th), H.R. 6800 (116th)

Budget/Appropriations BUD

Administration drug pricing proposals. Funding for HCV, HIV and public health activities via appropriations. H.R. 4378 - Continuing Appropriations Act and Health Extenders Act H.R. 1865 - Further Consolidated Appropriations Act, 2020 H.R. 3055 - Further Continuing Appropriations Act, 2020, and Further Health Extenders Act H.R. 1425 - Patient Protection and Affordable Care Enhancement Act

Contacted: State, Dept of (DOS); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE; White House Office; Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Commerce, Dept of (DOC); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Office of the Vice President of the United States

Bills named: H.R. 4378 (116th), H.R. 1425 (116th), H.R. 1865 (116th), H.R. 3055 (116th)